Kingsview Wealth Management LLC Boosts Position in CME Group Inc. (NASDAQ:CME)

Kingsview Wealth Management LLC boosted its position in CME Group Inc. (NASDAQ:CME) by 230.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,676 shares of the financial services provider’s stock after purchasing an additional 8,147 shares during the period. Kingsview Wealth Management LLC’s holdings in CME Group were worth $2,711,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Truvestments Capital LLC bought a new position in shares of CME Group in the 3rd quarter worth approximately $26,000. SJS Investment Consulting Inc. increased its holdings in CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after buying an additional 97 shares during the last quarter. Dunhill Financial LLC raised its position in CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 81 shares during the period. Financial Life Planners purchased a new position in shares of CME Group during the 4th quarter worth $32,000. Finally, Fortitude Family Office LLC grew its position in shares of CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 83 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Keefe, Bruyette & Woods decreased their target price on CME Group from $260.00 to $256.00 and set a “market perform” rating on the stock in a report on Monday, January 13th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research note on Monday, January 6th. Barclays boosted their price objective on CME Group from $231.00 to $257.00 and gave the company an “equal weight” rating in a research note on Monday, December 9th. Piper Sandler lifted their price target on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, January 7th. Finally, Morgan Stanley increased their price objective on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and an average price target of $229.27.

CME Group Price Performance

NASDAQ:CME opened at $244.83 on Monday. The business’s 50-day moving average is $235.48 and its 200 day moving average is $224.13. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $249.02. The company has a market capitalization of $88.23 billion, a P/E ratio of 25.74, a P/E/G ratio of 5.54 and a beta of 0.57. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be given a dividend of $1.25 per share. This is an increase from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 2.04%. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s dividend payout ratio is currently 48.37%.

CME Group announced that its Board of Directors has authorized a stock repurchase program on Thursday, December 5th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to reacquire up to 3.4% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board believes its stock is undervalued.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.